Type 2 diabetes: Preliminary results in Aliskiren trial show drug ‘may even be harmful’

Posted by & filed under Health Sciences.

Preliminary results from the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) do not support administration of aliskiren on top of standard therapy with renin-angiotensin-aldosterone system (RAAS) blockade in type 2 diabetics at high risk of cardiovascular and renal events, according to researchers. Researchers have now said the treatment "may even be harmful".

Comments are closed.

Feedback

eSTEM Feedback

We appreciate any and all feedback about our site; praise, ideas, bug reports you name it!

e.g. Indifferent, Undecided, Unconcerned e.g.Kidding, Amused, Silly e.g. Happy, Confident, Grateful e.g. Sad, Dissapointed, Confused, Angry